Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify patients that are more susceptible to the disease’s cognitive and physical decline. Erin Hascup, PhD, director of the Center for Alzheimer’s Disease and Related Disorders and associate professor in the Departments of Neurology and Pharmacology at Southern Illinois University (SIU) School of Medicine and Kevin Hascup, PhD, assistant professor in the Department of Neurology, Neuroscience Institute, are

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify patients that are more susceptible to the disease’s cognitive and physical decline. Erin Hascup, PhD, director of the Center for Alzheimer’s Disease and Related Disorders and associate professor in the Departments of Neurology and Pharmacology at Southern Illinois University (SIU) School of Medicine and Kevin Hascup, PhD, assistant professor in the Department of Neurology, Neuroscience Institute, are

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify patients that are more susceptible to the disease’s cognitive and physical decline. Erin Hascup, PhD, director of the Center for Alzheimer’s Disease and Related Disorders and associate professor in the Departments of Neurology and Pharmacology at Southern Illinois University (SIU) School of Medicine and Kevin Hascup, PhD, assistant professor in the Department of Neurology, Neuroscience Institute, are

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify patients that are more susceptible to the disease’s cognitive and physical decline. Erin Hascup, PhD, director of the Center for Alzheimer’s Disease and Related Disorders and associate professor in the Departments of Neurology and Pharmacology at Southern Illinois University (SIU) School of Medicine and Kevin Hascup, PhD, assistant professor in the Department of Neurology, Neuroscience Institute, are

content coming soon

content coming soon

SIU School of Medicine authors published 43 articles in the past month that were added to PubMed. Display the 43 citations in PubMed

The SIU Alton Family Medicine Residency Program is happy to offer some upcoming residency program informational sessions via Webex. Please join Program Director, Dr. M. Rebecca Hoffman, and Program Coordinator, Alison Witcher, for these 30-minute sessions to get your questions answered! Each session with begin with a short presentation of general program information and we will then open the session to attendees for questions. Please note that these sessions are not practice interview opportunities . Be prepared to arrive to the session(s) of your choice on time to ensure you hear the entire

M. Rebecca Hoffman, MD, MSPH, program director for the SIU Alton Family Medicine Residency Program, was selected as a LEADS Fellow for the 2020-21 year. The LEADS fellowship (Leadership Education for Academic Development and Success) is sponsored by the Association of Departments of Family Medicine (ADFM), the national group of family medicine department chairs and senior faculty. It is a 1-year national program designed for faculty who are exploring department chair or other senior academic family medicine roles. This fellowship provides experiential learning around the Family Medicine

Our program has another social media account. Please look for our logo and follow us @SIUAltonFM for updates!